GB1247306A - Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing same - Google Patents
Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing sameInfo
- Publication number
- GB1247306A GB1247306A GB41485/69A GB4148569A GB1247306A GB 1247306 A GB1247306 A GB 1247306A GB 41485/69 A GB41485/69 A GB 41485/69A GB 4148569 A GB4148569 A GB 4148569A GB 1247306 A GB1247306 A GB 1247306A
- Authority
- GB
- United Kingdom
- Prior art keywords
- glyoxylic acid
- preparation
- acid
- composition containing
- containing same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR164817A FR7736M (pl) | 1968-09-02 | 1968-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1247306A true GB1247306A (en) | 1971-09-22 |
Family
ID=8654167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB41485/69A Expired GB1247306A (en) | 1968-09-02 | 1969-08-20 | Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing same |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE737674A (pl) |
DE (1) | DE1944121A1 (pl) |
ES (1) | ES371093A1 (pl) |
FR (1) | FR7736M (pl) |
GB (1) | GB1247306A (pl) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704993B2 (en) | 2003-06-17 | 2010-04-27 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
US8153621B2 (en) | 2004-12-23 | 2012-04-10 | Arena Pharmaceuticals, Inc. | 5ht2C receptor modulator compositions |
US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
US8367657B2 (en) | 2003-06-17 | 2013-02-05 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
US8999970B2 (en) | 2010-09-01 | 2015-04-07 | Arena Pharmaceuticals, Inc. | Administration of an anti-obesity compound to individuals with renal impairment |
US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
US9169213B2 (en) | 2012-10-09 | 2015-10-27 | Arena Pharmaceuticals, Inc. | Method of weight management |
US9248133B2 (en) | 2010-09-01 | 2016-02-02 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
US9365521B2 (en) | 2010-09-01 | 2016-06-14 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-HT2C agonists |
US10226471B2 (en) | 2010-09-01 | 2019-03-12 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-HT2C agonists useful for weight management |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
PL1838677T3 (pl) | 2004-12-21 | 2010-02-26 | Arena Pharm Inc | Krystaliczne postacie agonisty chlorowodorku (R)-8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny |
-
1968
- 1968-09-02 FR FR164817A patent/FR7736M/fr not_active Expired
-
1969
- 1969-08-19 BE BE737674D patent/BE737674A/xx unknown
- 1969-08-20 GB GB41485/69A patent/GB1247306A/en not_active Expired
- 1969-08-30 DE DE19691944121 patent/DE1944121A1/de active Granted
- 1969-09-01 ES ES371093A patent/ES371093A1/es not_active Expired
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8946207B2 (en) | 2003-06-17 | 2015-02-03 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
US7704993B2 (en) | 2003-06-17 | 2010-04-27 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
US9102627B2 (en) | 2003-06-17 | 2015-08-11 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
US8367657B2 (en) | 2003-06-17 | 2013-02-05 | Arena Pharmaceuticals, Inc. | Processes for preparing 3-benzazepines |
US8404675B2 (en) | 2003-06-17 | 2013-03-26 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases |
US8546378B2 (en) | 2004-12-23 | 2013-10-01 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
US8153621B2 (en) | 2004-12-23 | 2012-04-10 | Arena Pharmaceuticals, Inc. | 5ht2C receptor modulator compositions |
US8501935B2 (en) | 2006-04-03 | 2013-08-06 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8802845B2 (en) | 2006-04-03 | 2014-08-12 | Arena Phamaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8168782B2 (en) | 2006-04-03 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto |
US8299241B2 (en) | 2006-12-05 | 2012-10-30 | Arena Pharmaceuticals, Inc. | Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof |
US8822727B2 (en) | 2008-03-04 | 2014-09-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-HT2C agonist (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
US9045431B2 (en) | 2010-06-02 | 2015-06-02 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
US8999970B2 (en) | 2010-09-01 | 2015-04-07 | Arena Pharmaceuticals, Inc. | Administration of an anti-obesity compound to individuals with renal impairment |
US9248133B2 (en) | 2010-09-01 | 2016-02-02 | Arena Pharmaceuticals, Inc. | Salts of lorcaserin with optically active acids |
US9365521B2 (en) | 2010-09-01 | 2016-06-14 | Arena Pharmaceuticals, Inc. | Non-hygroscopic salts of 5-HT2C agonists |
US9770455B2 (en) | 2010-09-01 | 2017-09-26 | Arena Pharmaceuticals, Inc. | Administration of an anti-obesity compound to individuals with renal impairment |
US10226471B2 (en) | 2010-09-01 | 2019-03-12 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-HT2C agonists useful for weight management |
US10463676B2 (en) | 2010-09-01 | 2019-11-05 | Arena Pharmaceuticals, Inc. | Modified-release dosage forms of 5-HT2C agonists useful for weight management |
US9169213B2 (en) | 2012-10-09 | 2015-10-27 | Arena Pharmaceuticals, Inc. | Method of weight management |
Also Published As
Publication number | Publication date |
---|---|
BE737674A (pl) | 1970-02-02 |
FR7736M (pl) | 1970-03-09 |
ES371093A1 (es) | 1971-08-16 |
DE1944121A1 (de) | 1970-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1247306A (en) | Heterocyclic derivatives of glyoxylic acid, process for their preparation and therapeutical composition containing same | |
GB1432576A (en) | Substituted phenylacetic acids | |
GB1305793A (pl) | ||
IE40695B1 (en) | Process for the manufacture of 7-amino-cephem-3-ol-4 carboxylic acid compounds | |
ES448394A1 (es) | Procedimiento para la obtencion de esteres de alcoxialquil- hidropiridina. | |
GB1243208A (en) | Improved synthesis of arylchlorocarbonyl ketenes | |
GB1373212A (en) | Pyrazole compounds | |
GB1355147A (en) | Oxoprostanoic acid derivatives | |
GB1265279A (pl) | ||
GB1314830A (en) | Pharmaceutically useful benzomorphanes and their production | |
GB1252329A (pl) | ||
GB1432503A (en) | Cycloalkylalkylesters and process for their preparation | |
GB1424415A (en) | Prostaglandin intermediates and their preparation | |
GB1411700A (en) | Penicillins and production thereof | |
FR2445314A1 (fr) | Procede de preparation d'acide 2-(3-phenoxy-phenyl)-propionique | |
ES8404326A1 (es) | Un procedimiento para preparar el nuevo compuesto ester guayacilico del acido 1-metil-5-p-toluilpirrol-2-acetico. | |
ES435604A1 (es) | Procedimiento para la preparacion de derivados de indolila- cetilaminoacidos. | |
GB1464431A (en) | Indolobenzazepine derivatives and a process for the manufacture thereof | |
GB1219387A (en) | Bicyclo[2.2.2]oct-2-ene-amino acid compounds | |
GB1410275A (en) | Phenoxycarboxylic acid derivatives their preparation and compositions containing them | |
GB1300419A (en) | New morphinone derivatives and their preparation | |
GB1069337A (en) | Basically substituted bis-naphthalimides and their production | |
GB1428933A (en) | 5-phenyl-sulphinyl-2-benzimidazolyl-carbamic acid esters and process for their manufacture | |
GB1283900A (en) | Therapeutically useful compounds and process for their preparation | |
GB1468333A (en) | Ketoglutaric acid derivatives |